Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
20 earlier
Committee on Veterans' Affairs. Hearings held. Hearings printed: S.Hrg. 119-86.
Original title: “S 219: Veterans Health Care Freedom Act”
Information about using PrEP for HIV prevention.
Original title: “Preventing HIV with PrEP”
The Food and Drug Administration (FDA, the Agency, or we) is announcing a public meeting entitled "Increasing Access to Nonprescription Drugs." The purpose of the public meeting is to discuss perspectives from interested parties on increasing access to nonprescription drugs. We are also requesting comments.
Original title: “Increasing Access to Nonprescription Drugs; Public Meeting; Request for Comments”
The Food and Drug Administration (FDA or the Agency) is announcing the following public meeting titled "Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments." The topic to be discussed is the financial transparency and efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments.
Original title: “Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments”
The U.S. Department of Health and Human Services (HHS) Office of Minority Health (OMH) hereby gives notice that OMH is accepting nominations of candidates to serve as primary and alternate delegates for the Center for Indigenous Innovation and Health Tribal Advisory Committee (CIIH TAC). OMH established the CIIH TAC to provide Tribal leaders a forum to exchange views, share information, and provide feedback to OMH on the development of activities addressing the four CIIH priority areas. The CIIH
Original title: “HHS OMH Call for Nominations for Center for Indigenous Innovation and Health”
This notice announces the public meeting of the Advisory Council on Alzheimer's Research, Care, and Services (Advisory Council). The Advisory Council provides advice on how to prevent or reduce the burden of Alzheimer's disease and related dementias on people living with the disease and their caregivers. During the second meeting of 2026, Advisory Council members will hear updates from federal agencies on activities during the last quarter and presentations focused on advancements in long-term s
Original title: “Advisory Council on Alzheimer's Research, Care, and Services; Meeting”
Pursuant to the Head Start Act, notice is hereby given of one Tribal Consultation session to be held between HHS/ACF OHS leadership and the leadership of tribal governments operating Head Start and Early Head Start programs. The purpose of this consultation session is to discuss ways to better meet the needs of American Indian and Alaska Native (AIAN) children and their families, taking into consideration funding allocations, distribution formulas, and other issues affecting the delivery of Head
Original title: “Tribal Consultation Meeting”
The draft guidance supports the agency’s new pathway designed to speed up the development of custom gene therapies.
Original title: “FDA bolsters bespoke therapy framework with new draft safety guidelines”
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Original title: “S 1878: ATTAIN Mental Health Act”
Referred to the House Committee on Ways and Means.
Original title: “HR 5376: Impacts and Outcomes for Health Career Training Act”
Some 30% of clinical trials that are mandated to report their findings have not posted results to clinicaltrials.gov, the federal government’s public repository for studies, according to internal data from the FDA.
Original title: “FDA asks 2,200 drug developers to make trial results public, ramping up transparency push”
Referred to the House Committee on Energy and Commerce.
Original title: “HR 8209: To amend the Public Health Service Act to reauthorize the school-based health centers grant program.”
Referred to the House Committee on Energy and Commerce.
Original title: “HR 8201: To amend Public Health Service Act to require community health centers to provide behavioral and mental health and substance use disorder services, and for other purposes.”
Referred to the Committee on Foreign Affairs, and in addition to the Committees on Armed Services, and Intelligence (Permanent Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Original title: “HR 8011: SECURE Health Act”
This proposed rule would revise the Medicare hospital inpatient prospective payment systems (IPPS) for operating and capital- related costs of acute care hospitals; make changes relating to Medicare graduate medical education (GME) for teaching hospitals; update the payment policies and the annual payment rates for the Medicare prospective payment system (PPS) for inpatient hospital services provided by long-term care hospitals (LTCHs); update and make changes to requirements for certain quality
Original title: “Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; and Other Policy Changes”